Your browser doesn't support javascript.
loading
Research progress on antitumor activity of XRP44X and analogues as microtubule targeting agents.
Wang, Chao; Shi, Lingyu; Yang, Shanbo; Chang, Jing; Liu, Wenjing; Zeng, Jun; Meng, Jingsen; Zhang, Renshuai; Xing, Dongming.
Afiliación
  • Wang C; Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
  • Shi L; Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
  • Yang S; School of Basic Medicine, Qingdao University, Qingdao, China.
  • Chang J; Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
  • Liu W; School of Basic Medicine, Qingdao University, Qingdao, China.
  • Zeng J; Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
  • Meng J; School of Basic Medicine, Qingdao University, Qingdao, China.
  • Zhang R; Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
  • Xing D; School of Basic Medicine, Qingdao University, Qingdao, China.
Front Chem ; 11: 1096666, 2023.
Article en En | MEDLINE | ID: mdl-36936533
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Chem Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Chem Año: 2023 Tipo del documento: Article País de afiliación: China